We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Blake Forman

Blake Forman profile page

Senior Science Writer

 at Technology Networks

Blake pens and edits breaking news, articles and features on a broad range of scientific topics. Blake earned an honors degree in chemistry from the University of Surrey, which involved a placement year at the Medicines and Healthcare products Regulatory Agency (MHRA) laboratory, where he developed new pharmaceutical testing methods. Blake also holds an MSc in chemistry from the University of Southampton. His research project focused on the synthesis of novel fluorescent dyes often used as chemical/bio-sensors and as photosensitizers in photodynamic therapy. Blake held several editorial-based roles before joining Technology Networks in 2024.


Education

University of Surrey  

University of Southampton  


Areas of Expertise

Analysis & Separations
Mass Spectrometry
Liquid Chromatography
Pharmacovigilance
Drug Discovery
Science Communication

Got a Question for Blake Forman?

Get in touch using the contact form linked here and we’ll get back to you shortly.



Published Content
Total: 66
A researcher in a hard hat and safety vest conducting environmental monitoring at a wastewater treatment facility
Article

Non-Target Screening Is Shaping Environmental Monitoring Strategies

Discover how regulators are utilizing non-target and suspect screening to detect and prioritize emerging contaminants, shaping environmental monitoring strategies.
Person interacting with a laptop displaying AI-powered analytics dashboards and data visualizations
Whitepaper

Reimagine Lab Efficiency With AI and Automation

This article highlights how these technologies address current bottlenecks, transforming research environments and optimizing scientific output.
Visualization of bacteriophages attaching to a bacterial cell, illustrating phage therapy concepts
Article

Harnessing Synthetic Biology for Phage Therapy and Probiotic Development

Synthetic biology techniques have emerged as transformative tools in the tug-of-war between humans and drug-resistant bacteria. Discover how researchers are utilizing synthetic biology techniques to engineer new antimicrobials.
Microscopic view of drug-resistant bacteria
News

“Achilles Heel” of Drug-Resistant TB Identified Using CRISPR Interference

Researchers have used whole-genome CRISPR interference screening to identify the “Achilles Heel” of drug-resistant tuberculosis and identify drugs that target these weaknesses to rapidly kill drug-resistant strains.
Researchers in a laboratory discussing data on a tablet, representing innovation in UK biotech startups.
Industry Insight

A Glimpse Into the Technologies Behind Upcoming UK Biotech Start-Ups

The Discovery Spark program aims to help upcoming biotechnology and healthcare companies grow. In this article, we take a closer look at some of the innovative technologies of this year's Discovery Spark cohort.
A separation scientist in a chromatography lab holding vials of solvent
Industry Insight

Current Trends and Emerging Technologies in Separation Science

Dr. Anthony Edge, chair of ISC 2024 and chair of the Permanent Scientific Committee of ISC, discusses some of the key takeaways from this year's meeting and explores the technologies set to transform separation science.
Gut bacteria inside the small intestines
News

How Opportunistic Bacteria Trigger Neuroinflammation via the Gut-Brain Axis

A study from Florida State University is the first to show a direct correlation between K. pneumoniae infection and Alzheimer’s pathology. The findings emphasize the potential risk hospital-acquired infections pose.
A molecule inside a red and blue drug capsule
Industry Insight

Three Technologies Set To Transform Drug Discovery in 2025 and Beyond

Technology Networks asked a selection of startups featured in the ELRIG Drug Discovery 2024 Breakthrough Zone how their technology might reshape the pharmaceutical industry and pave the way for the next generation of therapeutic discovery.
Microscopic image of colorectal cells grown into organoids
Industry Insight

In Vitro Models To Advance Preclinical Drug Development

Dr. Emanuela Costigliola discusses recent advances in preclinical drug development and the significance of physiologically relevant models in predicting human responses.
A female scientist in a cleanroom lab seen tapping on the screen of an instrument used in the pharmaceutical industry
Industry Insight

Scaling iPSC-Derived Cell Therapies From Innovation to Patient Care

In an interview with Technology Networks, Dr. Frederic Cedrone, vice president of corporate innovation at Catalent, discussed the challenges faced and solutions found by companies developing iPSC-derived cell therapies.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter